Literature DB >> 21125172

Vaccination practice in children with rheumatic disease.

Clovis Artur A Silva1, Maria Teresa R A Terreri, Nadia E Aikawa, Jozélio F Carvalho, Gecilmara C S Pileggi, Virginia P L Ferriani, Cássia Maria P L Barbosa, Maria Odete E Hilário, Adriana A Jesus, Adriana M E Sallum, Ana Paola N Lotito, Bernadete L Liphaus, Claudia S Magalhães, Cláudio A Len, Eunice M Okuda, Lucia Maria M Campos, Luciana M Carvalho, Marcos Vinícius Ronchezel, Maria Carolina dos Santos, Paulo Roberto S Romanelli, Roberto Marini, Rosa Maria R Pereira, Silvana B Sacchetti, Simone Lotufo, Wanda A Bastos.   

Abstract

INTRODUCTION/
OBJECTIVES: Evaluate clinical practice through assessment of vaccination card and recommendation of specific vaccines in pediatric patients with rheumatic diseases in use of different drugs and reveal the possible association between vaccination frequency and time of the clinical practice of pediatric rheumatologists in the state of São Paulo.
MATERIAL AND METHODS: A questionnaire was sent to pediatric rheumatologists of the Departamento de Reumatologia da Sociedade de Pediatria de São Paulo. This instrument included questions about practice time on Pediatric Rheumatology, vaccination of patients with juvenile systemic lupus erythematosus (JSLE), juvenile idiopathic arthritis (JIA), juvenile dermatomyositis (JDM), and immunization according to the treatments used.
RESULTS: Vaccination card was seen by 100% of the professionals at the first visit and by 36% annually. Vaccines of live agents were not recommended for patients with JSLE, JIA, and JDM in 44%, 64%, and 48%, respectively. The professionals were divided into two groups: Group A (≤ 15 years of practice, n = 12) and B (≥ 16 years, n = 13). No statistical difference was observed in the use of live agent vaccine and vaccines with inactivated agents or protein components in the two treatment groups (P > 0.05). Moreover, the groups had similar opinion regarding severity of immunosuppression in patients with JSLE, JIA, and JDM (with or without activity) and treatment used (P > 0.05).
CONCLUSIONS: The frequency of immunization by pediatric rheumatologists in São Paulo is low, especially after the first visit, and not influenced by time of professional practice.

Entities:  

Mesh:

Year:  2010        PMID: 21125172

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  7 in total

Review 1.  Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review.

Authors:  Vincent Gosselin Boucher; Sandra Pelaez; Claudia Gemme; Sara Labbe; Kim L Lavoie
Journal:  Clin Rheumatol       Date:  2020-07-03       Impact factor: 2.980

Review 2.  Vaccinations in juvenile chronic inflammatory diseases: an update.

Authors:  Clovis A Silva; Nadia E Aikawa; Eloisa Bonfa
Journal:  Nat Rev Rheumatol       Date:  2013-07-02       Impact factor: 20.543

3.  Vaccinations Do Not Increase Arthritis Flares in Juvenile Idiopathic Arthritis: A Study of the Relationship between Routine Childhood Vaccinations on the Australian Immunisation Schedule and Arthritis Activity in Children with Juvenile Idiopathic Arthritis.

Authors:  Naba M Alfayadh; Peter J Gowdie; Jonathan D Akikusa; Mee Lee Easton; Jim P Buttery
Journal:  Int J Rheumatol       Date:  2020-08-04

Review 4.  Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.

Authors:  Piyush Ranjan; Avinash Chakrawarty; Archana Kumari; Jitendra Kumar
Journal:  J Clin Diagn Res       Date:  2015-05-01

5.  Assessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy.

Authors:  Izabela Szczygielska; Elżbieta Hernik; Agnieszka Gazda; Beata Kołodziejczyk; Piotr Gietka
Journal:  Reumatologia       Date:  2020-02-28

6.  Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases.

Authors:  Nádia Emi Aikawa; Verena Andrade Balbi; Eduardo Ferreira Borba; Adriana Coracini Tonacio; Adriana Maluf Elias Sallum; Lucia Maria Arruda Campos; Kátia Tomie Kozu; Margarete Borges Vendramini; Nicole Fontoura; Adriana de Souza Azevedo; Waleska Dias Schwarcz; Ana Marli Christovam Sartori; Leila Antonangelo; Clovis Artur Silva; Eloisa Bonfá
Journal:  Vaccine X       Date:  2021-12-10

7.  TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients.

Authors:  Ivan Leonardo Avelino França; Ana Cristina Medeiros Ribeiro; Nádia Emi Aikawa; Carla Gonçalves Schain Saad; Julio Cesar Bertacine Moraes; Cláudia Goldstein-Schainberg; Ieda Maria Magalhães Laurindo; Alexander Roberto Precioso; Maria Akiko Ishida; Ana Marli Christovam Sartori; Clovis Artur Silva; Eloisa Bonfa
Journal:  Rheumatology (Oxford)       Date:  2012-08-20       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.